Roivant Sciences (ROIV) Enterprise Value (2021 - 2026)
Roivant Sciences (ROIV) posted Enterprise Value of -$1.1 billion for Q1 2026, up 72.23% on a QoQ basis from -$3.8 billion in Q4 2025, and up 57.83% year-over-year from -$673.0 million in Q1 2025.
Roivant Sciences (ROIV) Enterprise Value (2021 - 2026) Analysis & Trends
Roivant Sciences' Enterprise Value history runs 6 years deep, the most recent figure standing at -$1.1 billion for Q1 2026.
- Quarterly Enterprise Value rose 57.83% year-over-year to -$1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.1 billion (up 57.83% YoY) and the FY2026 annual result came in at -$1.1 billion, up 57.83% from the prior year.
- Enterprise Value was -$1.1 billion for Q1 2026 at Roivant Sciences, up from -$3.8 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$42.6 million in Q4 2024 and bottomed at -$6.4 billion in Q4 2023.
- A 5-year average of -$2.7 billion and a median of -$1.9 billion in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value surged 99.34% — and 2025, when it slumped 8873.63%.
- Roivant Sciences' Enterprise Value stood at -$1.8 billion in 2022, then slumped by 258.08% to -$6.4 billion in 2023, then jumped by 99.34% to -$42.6 million in 2024, then slumped by 8873.63% to -$3.8 billion in 2025, then soared by 72.23% to -$1.1 billion in 2026.
- Business Quant data shows ROIV's Enterprise Value at -$1.1 billion in Q1 2026, -$3.8 billion in Q4 2025, and -$3.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | -1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.06 Bn |
| Dec 31, 2025 | -3.83 Bn |
| Sep 30, 2025 | -3.94 Bn |
| Jun 30, 2025 | -4.03 Bn |
| Mar 31, 2025 | -2.52 Bn |
| Dec 31, 2024 | -42.63 Mn |
| Sep 30, 2024 | -1.89 Bn |
| Jun 30, 2024 | -5.50 Bn |
| Mar 31, 2024 | -6.02 Bn |
| Dec 31, 2023 | -6.45 Bn |
| Sep 30, 2023 | -1.27 Bn |
| Jun 30, 2023 | -1.31 Bn |
| Mar 31, 2023 | -1.23 Bn |
| Dec 31, 2022 | -1.80 Bn |
| Sep 30, 2022 | -1.25 Bn |
| Jun 30, 2022 | -1.57 Bn |
| Mar 31, 2022 | -2.36 Bn |
| Dec 31, 2021 | -2.18 Bn |
| Sep 30, 2021 | -2.91 Bn |
| Jun 30, 2021 | -2.15 Bn |